Joshua M. Hauser

Nov 15, 2024 | jamanetwork.com | Joshua M. Hauser |Rita F. Redberg |Ali Abbasi

To the Editor Robust and high-quality evidence generation for new drugs and devices benefits many parties. Ensuring that this evidence proves that treatments are beneficial is essential. As our health care system operates like a speeding train with no brakes immediately following US Food and Drug Administration (FDA) approval, reasonable evidence that benefits exceed harms must be obtained before approval.

May 1, 2024 | spcare.bmj.com | Brian Cheng |Joshua M. Hauser

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. View Full Text Read the full text or download the PDF: